कंपनी का अवलोकन
Option Care Health, Inc. operates as a prominent provider within the Healthcare sector, specifically specializing in the Medical Care Facilities industry by delivering home and alternate site infusion services throughout the United States. This business model focuses on administering critical therapies such as anti-infective treatments, heart failure management, and nutritional support for both acute and chronic patient conditions. The company demonstrates a substantial operational scale, evidenced by a total market capitalization of $4.40B and an annualized revenue stream of $5.65B. Furthermore, the organization employs a workforce of 6,528 individuals, indicating a mature infrastructure capable of supporting extensive service delivery networks. These valuation and revenue figures collectively suggest that Option Care Health holds a significant position within its niche, balancing the high costs of medical service provision with a robust top-line performance that supports its market standing.
वित्तीय स्वास्थ्य
The financial performance of the company over the trailing twelve months (TTM) is characterized by $5.65B in revenue, which generated $207.58M in net income and $408.60M in EBITDA. The notable disparity between the $5.65B revenue and the $207.58M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative overhead, absorb approximately 96.3% of total sales. This results in a free cash flow of $172.75M, which provides the organization with essential financial flexibility to fund operations, manage debt obligations, and potentially invest in infrastructure without relying solely on external capital markets. Profitability analysis shows a gross margin of 19.3%, reflecting the high variable costs associated with infusion services; an operating margin of 6.2% indicates moderate efficiency in managing overhead; and a profit margin of 3.7% highlights the capital-intensive nature of the medical care facility business. Regarding liquidity and leverage, the company holds $238.12M in cash against $1.27B in total debt, resulting in a debt-to-equity ratio of 96.00, which suggests a leveraged balance sheet reliant on equity markets or refinancing to service obligations. The current ratio stands at 1.52, indicating that the company possesses sufficient current assets to cover its short-term liabilities, though with a moderate safety margin. Additionally, the Return on Equity (ROE) of 15.2% and Return on Assets (ROA) of 6.1% demonstrate that management is effectively utilizing shareholders' equity and total assets to generate returns, despite the high leverage present in the capital structure.
मूल्यांकन आकलन
Valuation metrics for Option Care Health, Inc. indicate a trailing P/E ratio of 21.84 compared to a forward P/E of 13.05, suggesting that the market expects a significant acceleration in earnings growth relative to current levels. The price-to-book ratio is recorded at 3.28, implying that the market values the company at more than three times its tangible book value, potentially reflecting intangible assets or growth expectations not fully captured on the balance sheet. Alternative valuation measures include a price-to-sales ratio of 0.78 and an EV/EBITDA multiple of 13.15, which provide context by comparing the stock price to revenue and earnings before interest, taxes, depreciation, and amortization, respectively. The stock has traded between a 52-week high of $36.80 and a 52-week low of $24.24; without the specific current share price listed in the provided facts, the exact percentage distance from these extremes cannot be calculated, but the range establishes the volatility bounds for the security. The beta value of 0.95 indicates that the stock's price volatility is roughly in line with the broader market, meaning it does not exhibit extreme sensitivity to market movements compared to high-beta or low-beta peers.
Growth & Income
Revenue growth for the trailing twelve months stands at 8.8%, while earnings growth is recorded at 1.3%, indicating that earnings are expanding at a significantly slower pace than revenue. This divergence often implies that cost pressures or one-time items are impacting the bottom line, as the profit margin expansion has not kept pace with the top-line expansion. As the company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it retains all net income for reinvestment into business growth, debt reduction, or shareholder buybacks rather than providing periodic cash returns to investors. Consequently, the overall growth and income profile is driven entirely by capital appreciation potential and operational expansion within the home infusion market rather than a yield strategy. The absence of a dividend program aligns with the company's stage of development or capital allocation priorities, focusing resources on maintaining the high asset turnover required in the medical care facilities industry.